Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography
- PMID: 2916435
- DOI: 10.1016/0002-9149(89)90325-1
Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography
Abstract
A double-blind randomized study was performed in 60 patients to compare the electrocardiographic and hemodynamic changes induced during cardiac angiography by 2 contrast media with relatively low osmolality. Ioxaglate meglumine sodium, an ionic dimer contrast medium, was compared with iopamidol, a nonionic compound. Of the 30 patients who received ioxaglate, 13 (43%) experienced a mild to moderate adverse reaction to the contrast media, while only 2 of the 30 patients (7%) in the iopamidol group had similar side effects (p less than 0.005). Significant prolongations of the QT intervals occurred with the ioxaglate injections. The QT intervals increased from 402 +/- 46 to 442 +/- 59 ms (p less than 0.001) with the right coronary artery injection and similar changes were observed after the left coronary artery injection and left ventriculography. Significant ST-segment and T-wave amplitude changes also occurred in the ioxaglate group. With iopamidol injections, there were no significant changes in any of these parameters. After the left ventriculogram, there were similar decreases in the systolic arterial pressures in both groups (-14 +/- 10 mm Hg with ioxaglate and -21 +/- 9 mm Hg with iopamidol). The left ventricular end-diastolic pressures increased after the ventriculogram in both groups (5 +/- 5 vs 2 +/- 3 mm Hg with ioxaglate and iopamidol, respectively, 60 seconds after the injection). This report demonstrates that mild to moderate adverse reactions, QT-interval prolongations, ST and T-wave changes were significantly greater during coronary angiography with ioxaglate when compared with iopamidol.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
A multicenter randomized trial of ionic (ioxaglate) and nonionic (iopamidol) low-osmolality contrast agents in cardiac angiography.Clin Cardiol. 1989 Dec;12(12):689-96. doi: 10.1002/clc.4960121204. Clin Cardiol. 1989. PMID: 2692891 Clinical Trial.
-
Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study.J Am Coll Cardiol. 1992 Apr;19(5):899-906. doi: 10.1016/0735-1097(92)90268-r. J Am Coll Cardiol. 1992. PMID: 1552109 Clinical Trial.
-
Comparison between a low-osmolar ionic (ioxaglate) and a low-osmolar non-ionic (iopamidol) contrast agent in cardiac imaging.S Afr Med J. 1988 Feb 6;73(3):168-71. S Afr Med J. 1988. PMID: 3340942 Clinical Trial.
-
[Significance of low osmolarity contrast media in state of the art roentgen diagnosis].Orv Hetil. 1989 Jun 18;130(25):1317-21. Orv Hetil. 1989. PMID: 2664636 Review. Hungarian.
-
A survey of contrast media used in coronary angiography.Cardiovasc Intervent Radiol. 1982;5(3-4):202-10. doi: 10.1007/BF02552311. Cardiovasc Intervent Radiol. 1982. PMID: 6217892 Review.
Cited by
-
Comparative tolerability of contrast media used for coronary interventions.Drug Saf. 2002;25(15):1079-98. doi: 10.2165/00002018-200225150-00003. Drug Saf. 2002. PMID: 12452733 Review.
-
PEGylation of Terminal Ligands as a Route to Decrease the Toxicity of Radiocontrast Re6-Clusters.Int J Mol Sci. 2023 Nov 21;24(23):16569. doi: 10.3390/ijms242316569. Int J Mol Sci. 2023. PMID: 38068892 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources